T1	Haplotype	0 20	In CYP3A5 * 1 allele
T2	Phenotype	32 49	CYP3A5 expressers
T3	Pharmacokinetic_phenotype	80 93	clearance was
T4	Phenotype	332 356	non-expressers ; however
T5	Limited_variation	378 391	variation did
T6	Pharmacokinetic_phenotype	417 441	chronopharmacokinetics .
R1	decreases	Arg1:T1	Arg2:T3
R2	influences	Arg1:T1	Arg2:T6
R3	isEquivalentTo	Arg1:T2	Arg2:T1
R4	decreases	Arg1:T2	Arg2:T3
R5	isAssociatedWith	Arg1:T2	Arg2:T5
R6	influences	Arg1:T2	Arg2:T6
R7	isAssociatedWith	Arg1:T3	Arg2:T1
R8	isAssociatedWith	Arg1:T3	Arg2:T2
R9	isAssociatedWith	Arg1:T3	Arg2:T4
R10	isAssociatedWith	Arg1:T3	Arg2:T5
R11	isAssociatedWith	Arg1:T3	Arg2:T6
R12	influences	Arg1:T4	Arg2:T1
R13	influences	Arg1:T4	Arg2:T2
R14	decreases	Arg1:T4	Arg2:T3
R15	influences	Arg1:T4	Arg2:T5
R16	influences	Arg1:T4	Arg2:T6
R17	influences	Arg1:T5	Arg2:T1
R18	influences	Arg1:T5	Arg2:T2
R19	influences	Arg1:T5	Arg2:T3
R20	influences	Arg1:T5	Arg2:T4
R21	influences	Arg1:T5	Arg2:T6
R22	isAssociatedWith	Arg1:T6	Arg2:T1
R23	isAssociatedWith	Arg1:T6	Arg2:T2
R24	decreases	Arg1:T6	Arg2:T3
R25	isAssociatedWith	Arg1:T6	Arg2:T4
R26	isAssociatedWith	Arg1:T6	Arg2:T5
